DRB (HIV Transcription Inhibitor): Unraveling RNA Polymer...
2025-10-18
Explore how 5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole (DRB), a potent transcriptional elongation inhibitor, uniquely intersects with RNA polymerase II dynamics, cyclin-dependent kinase signaling, and cell fate transitions. This in-depth analysis reveals DRB's emerging roles in HIV, antiviral, and stem cell research beyond conventional perspectives.